COMMUNIQUÉS West-GlobeNewswire
-
Evolution Physical Therapy Expands Athelas Partnership With AI Agents After Two Years of Improved Revenue Cycle Performance and Reduced Administrative Burden
18/11/2026 -
OnMed Announces CEO Transition: Thurman Justice to Succeed Karthik Ganesh
18/11/2026 -
CareMore Health and L.A. Care Expand Medicare Access in Los Angeles County
18/11/2026 -
Ossium Health Appoints Transplant and Cell Therapy Leader Edwin Horwitz, MD, PhD, as Executive Director of Medical Affairs
18/11/2026 -
Philips introduces Skylight Device Manager to turn ultrasound data into operational intelligence
18/11/2026 -
Profility Launches PReP Audits as AI-Driven Audits Expand Across Medicare and Medicaid
18/11/2026 -
Survey reveals care navigation gap when patients must decide when and where to get help
18/11/2026 -
Finish Strong, Start Strong: Austin Sports Medicine Experts Urge Athletes and Families to Prioritize Injury Recovery Before the New Year
18/11/2026 -
BC launches first-of-its-kind jointly held professorship in menopause research and education
18/11/2026 -
Texas Original’s Fort Worth Medical Cannabis Dispensary Now Offers Same-Day Access
18/11/2026 -
Commure Ranked No. 1 for Provider Satisfaction in KLAS 2026 Top 20 Report
18/11/2026 -
Virbac to Participate in the Jefferies Global Healthcare Conference in London
18/11/2026 -
Can-Fite Pivotal Phase III Psoriasis Study Under an FDA- and EMA-agreed protocol: All Patients Completed Dosing and Interim Analysis Expected Q1 2027
18/11/2026 -
Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
18/11/2026 -
Aquestive Therapeutics to Present at the Piper Sandler 38th Annual Healthcare Conference
18/11/2026 -
NervGen Appoints Neuroscience Drug Development Leader Sam Jackson, MD, MBA, as Chief Medical Officer
18/11/2026 -
Conavi Medical Announces Five-Year Extension of Credit Facilities with Japan Lifeline
18/11/2026 -
Optimi Health Outlines 2027 Plans for OPTI-101 Phase 2b in Major Depressive Disorder and OPTI-201 Phase 3 in PTSD; Announces Shares-for-Debt Settlement
18/11/2026 -
Immuneering Presents Data That Supports Expanding the Clinical Evaluation of Atebimetinib to Anaplastic Thyroid Cancer
18/11/2026
Pages